
GC19063
Belizatinib
Also known as 4-fluoro-N-[6-[[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl]-1-[4-(propan-2-ylcarbamoyl)cyclohexyl]benzimidazol-2-yl]benzamide
Belizatinib is an oral, dual, potent inhibitor of ALK and TRKA, TRKB, and TRKC, with IC50 of 0·7 nM for wild-type recombinant ALK kinase
ChemicalCAS1357920-84-3MW577.73FormulaC33H44FN5O3
- CAS number
- 1357920-84-3
- Molecular weight
- 577.73
- Formula
- C33H44FN5O3
- Solubility
- DMSO : ≥ 300 mg/mL (519·27 mM)
- InChIKey
- WSTUJEXAPHIEIM-UHFFFAOYSA-N
- Catalogue number
- GC19063
- Brand
- GLPBIO
Computed properties PubChem CID 57345941 · XLogP 4.5 · TPSA 99.5 Ų · H-bond donors 3
- XLogP
- 4.5
- TPSA
- 99.5 Ų
- H-bond donors
- 3
- H-bond acceptors
- 6
- Rotatable bonds
- 8
- Heavy atoms
- 42
SMILES CC(C)NC(=O)C1CCC(CC1)N2C3=C(C=CC(=C3)CN4CCC(CC4)C(C)(C)O)N=C2NC(=O)C5=CC=C(C=C5)F
Computed descriptors from PubChem (CID 57345941), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il